- Report
- October 2024
- 186 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- April 2025
- 93 Pages
Global
From €5308EUR$5,600USD£4,434GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- March 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- May 2024
- 133 Pages
Global
From €6160EUR$6,499USD£5,146GBP
- Report
- May 2024
- 131 Pages
Global
From €6160EUR$6,499USD£5,146GBP
- Report
- September 2024
- 343 Pages
Global
From €7535EUR$7,950USD£6,295GBP
- Drug Pipelines
- August 2024
- 150 Pages
Global
From €3554EUR$3,750USD£2,969GBP
- Report
- July 2024
- 150 Pages
Global
From €3554EUR$3,750USD£2,969GBP
- Report
- July 2024
- 100 Pages
Global
From €3554EUR$3,750USD£2,969GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3554EUR$3,750USD£2,969GBP
- Report
- April 2022
- 191 Pages
Global
From €4218EUR$4,450USD£3,524GBP
- Report
- November 2021
- 101 Pages
Global
From €4265EUR$4,500USD£3,563GBP
- Report
- August 2022
- 120 Pages
Global
From €4502EUR$4,750USD£3,761GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
€1422EUR$1,500USD£1,188GBP
- Report
- March 2023
- 147 Pages
Global
From €4691EUR$4,949USD£3,919GBP
- Report
- April 2023
- 115 Pages
Global
From €4502EUR$4,750USD£3,761GBP
- Report
- April 2023
- 117 Pages
Global
From €4502EUR$4,750USD£3,761GBP
- Report
- March 2024
- 200 Pages
Global
From €3933EUR$4,150USD£3,286GBP
- Report
- January 2023
- 167 Pages
Global
From €3412EUR$3,600USD£2,851GBP
Formoterol is a long-acting beta-2 agonist (LABA) used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It is a bronchodilator, meaning it relaxes the muscles in the airways, allowing more air to flow in and out of the lungs. Formoterol is typically used in combination with an inhaled corticosteroid (ICS) to provide long-term control of symptoms. It is also used as a rescue medication to provide quick relief from acute symptoms.
Formoterol is available in both metered-dose inhalers (MDIs) and dry powder inhalers (DPIs). It is also available in combination with other drugs, such as budesonide and mometasone. Formoterol is generally well-tolerated, with few side effects.
Formoterol is one of the most widely used drugs in the respiratory market. It is used to treat a variety of conditions, including asthma, COPD, and bronchospasm. It is also used as a rescue medication for acute symptoms.
Some companies in the Formoterol market include GlaxoSmithKline, Merck, Novartis, and Boehringer Ingelheim. Show Less Read more
